Clinical Trial Update: Oral 6R-BH4 for the Treatment of Isolated Systolic Hypertension and Endothelial Dysfunction [Phase 2]

View source ↗

Summary

Phase 2 trial of oral 6R-BH4 for isolated systolic hypertension and endothelial dysfunction was terminated; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endothelial Dysfunction
• Isolated Systolic Hypertension

Drugs mentioned

• 6R-BH4 (6R-tetrahydrobiopterin)

Snippet

Sponsor: Johns Hopkins University | Conditions: Isolated Systolic Hypertension, Endothelial Dysfunction | Phase 2 | Status: TERMINATED | Results posted: 2017-08-21